NAD+ therapy may not be appropriate for individuals with a known allergy to the medication or its components. It is generally not recommended for those who are pregnant or breastfeeding unless directed by a healthcare provider.
Individuals with certain cardiovascular or metabolic conditions should use caution. A licensed provider will determine eligibility during evaluation.